Zobrazeno 1 - 10
of 6 026
pro vyhledávání: '"unrelated donor transplantation"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1024-S1025 (2024)
Introduction: The EBMT recommends an ATG (Thymoglobulin) dose of 4.5‒6.0 mg/kg for an unrelated (URD) hematopoietic cell transplant (HCT). The PTCy-based Baltimore protocol for haploidentical (Haplo) HCT included MMF 45 mg/kg starting at D+5, howev
Externí odkaz:
https://doaj.org/article/e4250e2d5f8d45019263356d7a60e900
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fingrut WB; Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY., Scaradavou A; Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY., Barker JN; Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 06, pp. JCO2401824. Date of Electronic Publication: 2024 Nov 06.
Autor:
Shaffer BC; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Gooptu M; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., DeFor T; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Spellman SR; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Stefanski HE; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Shaw BE; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Auletta JJ; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Devine SM; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Jimenez AM; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Al Malki MM; Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD, and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL, and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 06, pp. JCO2402108. Date of Electronic Publication: 2024 Nov 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.